Huge shortages of estradiol patches

Transdermal patches from both Novartis and Bayer are experiencing a shortfall, predicted to last until November While the shortages to the Novartis products have been occurring since November last year due to manufacturing reasons, the TGA has now announced current and anticipated shortages of Bayer’s Climara 25 Transdermal Patches due to “unexpected increase in demand".